Pi3k/mtor kinase inhibitors

C - Chemistry – Metallurgy – 07 – D

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07D 413/04 (2006.01) A61K 31/519 (2006.01) A61K 31/5375 (2006.01) A61P 35/00 (2006.01) C07D 265/30 (2006.01) C07D 403/14 (2006.01) C07D 407/14 (2006.01) C07D 413/02 (2006.01) C07D 487/02 (2006.01) C07D 487/04 (2006.01)

Patent

CA 2743015

6-morpholin-4-yl-pyrazolo[3,4-d]pyrimidine and 2-morpholin-4-yl-7H-pyrrolo[2,3- d]pyrimidine derivatives have unexpected drug properties as inhibitors of PI3 and/or mTOR kinases and are useful in treating disorders related to abnormal PI3K/mTOR activities such as cancer, immune disorders, cardiovascular disease, viral infection, inflammation, metabolism/endocrine disorders and neurological disorders.

Linvention concerne des dérivés de 6-morpholin-4-yl-pyrazolo[3,4-d]pyrimidine et de 2-morpholin-4-yl-7H- pyrrolo[2,3-d]pyrimidine possédant des propriétés inattendues dinhibiteurs des PI3K et/ou mTOR kinases et utilisés pour traiter les troubles associés à lactivité anormale de PI3K/mT0R, tels que le cancer, les troubles immunitaires, les maladies cardio-vasculaires, les infections virales, les troubles du métabolisme/de lendocrine et les troubles neurologiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pi3k/mtor kinase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pi3k/mtor kinase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pi3k/mtor kinase inhibitors will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1857131

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.